Engaging patients and patient advocacy organizations (PAOs) in the rare disease drug development process has a significant impact. The abstract aims to increase awareness of ways the patient community serves as a valued partner of drug developers and spotlights the contribution of patient voices and PAOs in the research and drug development process.